An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on ...

  Serum Institute of India (SII) CEO Adar Poonawala on Friday said it has applied to Indian authorities for full market authorisation of Covishield, stating supplies of the Covid-19 vaccine have...

Serum Institute of India (SII) plans to launch a COVID-19 vaccine for children in the next six months, the company's CEO Adar Poonawalla said on Tuesday. Participating in an industry conference, ...

Serum Institute of India chief Adar Poonawalla, in an exclusive interview to NDTV, said a version of Covishield, tailor made for the new Covid variant Omicron can be considered if research indicates a...

Prime Minister Narendra Modi, West Bengal Chief Minister Mamata Banerjee and Serum Institute of India CEO Adar Poonawalla have been named among the world's 100 most influential people of 2021 by T...

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and ...

Vaccine major Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its Covid-19 vaccine Covishield in a month, company's chief executive officer...

Sources said referring to Poonawalla's letter, Director, Government and Regulatory Affairs at SII, Prakash Kumar Singh, has also sought Jaishankar's intervention at the highest level, saying, ...

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII CEO Adar Poonawalla said on Friday. "Excit...

The French-born CEO of AstraZeneca, Pascal Soriot, has insisted that despite setbacks his Covid vaccine has a future and hit out at the “armchair generals” behind the “traumatic atta...